Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
From the mechanistic contributions of pathogenic bacteria to tumor initiation, to the role dysbiosis plays in influencing systemic cancer behavior, understand the impact bacteria has as a driver of cancer development.
Among people with cancer, the presence of fatigue before starting treatment is associated with an increased risk for severe, life-threatening, or fatal adverse events.
Recent trials have shown survival benefits of intensified regimens in EGFR-mutant NSCLC, but they come at the cost of increased toxicity and treatment burden. So which patients should receive upfront intensification?
Familiarize yourself with the current evidence on risk factors, molecular pathology, and treatment strategies for lung cancer in nonsmoking women, and understand the critical role of gender susceptibility.
A complicated case in which a patient admitted with polyuria and polydipsia was diagnosed with arginine vasopressin deficiency, which was ultimately found to be a manifestation of lung cancer.
In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.
This content is intended only for US-based healthcare providers.
A complicated case in which a patient admitted with polyuria and polydipsia was diagnosed with arginine vasopressin deficiency, which was ultimately found to be a manifestation of lung cancer.
An extremely rare case of combined small-cell lung cancer with adenocarcinoma. Such variants can be difficult to diagnose and treat. How would you manage this patient?
Small-cell lung cancer (SCLC) can show extensive angiogenesis, but direct arterial feeders arising from coronary vessels are exceedingly rare. We report a case where the left circumflex artery perfusing the tumor was successfully treated with coil embolization.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
Chemotherapy remains a mainstay in managing advanced and metastatic solid tumors, but its hematologic toxicity may restrict its application [ 1 ]. Chemotherapy-induced myelosuppression (CIM) is one of the common side effects of systemic …
Lung cancer is currently the most common cancer worldwide, with almost 2.5 million diagnoses and 1.8 million deaths in 2022. The disease is responsible for nearly one in five cancer deaths (18.7%) [ 1 ], with a low global five-year survival rate …
Multidrug resistance (MDR) still constitutes a significant barrier to the effective treatment of lung cancer and makes a significant contribution to the poor clinical results. MDR is explained by a set of mechanisms; increase of drug efflux …
The ADAURA trial has, as of this year, demonstrated an overall survival benefit with the adjuvant use of osimertinib in people with resectable NSCLC.
We take an in-depth look at the study with Dr. Luis Paz-Ares, who outlines the study findings, discusses the clinical implications, and addresses the pertinent questions raised by the trial.
In this interactive webinar, experts discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.
This content is intended only for US-based healthcare providers.
Expert-led, multiformat program which addresses the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Use the guidance on integrating shared decision making into clinical practice, drawing on insights from a patient on how best to communicate.
Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.
Radiotherapy is a critical modality in the treatment of lung cancer. Evidence-based indications for radiotherapy apply to 77% of all lung cancer patients [ 1 ]. However, an evidence-based population modelling study of the overall lung cancer …
Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy accounting for approximately 15% of all lung cancers and is characterized by rapid proliferation, early systemic dissemination, and poor long-term outcomes [ 1 ]. Despite high …
Lung cancer remains a worldwide leading cause of cancer-related morbidity and mortality. The International Agency for Research on Cancer has estimated about 2.48 million new cases of lung cancer and 1.8 million deaths in 2022 [ 1 ]. Most patients …
From the mechanistic contributions of pathogenic bacteria to tumor initiation, to the role dysbiosis plays in influencing systemic cancer behavior, understand the impact bacteria has as a driver of cancer development.